Tata India Pharma & Healthcare Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1383 Cr | ₹1208 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 28 Sep 2023 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.17 | 2.14 |
| Manager | Dhruv Muchhal | Meeta Shetty |
| ISIN Code | INF179KC1HL7 | INF277K016A9 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -2.19% | -3.04% |
| 6 Month | 18.27% | 9.88% |
| 1 Year | 37.62% | 27.65% |
| 3 Year | - | 20.65% |
| 5 Year | - | 25.56% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 33.18% | 19.99% |
| 3 Year | - | 29.34% |
| 5 Year | - | 23.84% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 62.28% | 6.67% |
| 3 Year | - | 17.46% |
| 5 Year | - | 14.22% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | - | 14.23% |
| Sharp | - | 0.74% |
| Beta | - | 0.9% |
| Alpha | - | 2.85% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Dhruv Muchhal | Meeta Shetty |
| Total AUM | ₹520687 Cr | ₹17847 Cr |
| Fund Manage | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.98 | 5.39 |
| Small Cap | 33.12 | 23.46 |
| Large Cap | 32.5 | 40.33 |
| Mid Cap | 32.4 | 30.82 |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.98 | 5.39 |
| Pharmaceuticals & Biotechnology | 74.71 | 76.28 |
| Healthcare Services | 22.28 | 14.31 |
| Retailing | 1.03 | 0.66 |
| Fertilizers & Agrochemicals | - | 0.83 |
| Chemicals & Petrochemicals | - | 0.39 |
| Insurance | - | 2.14 |
Top Comparisons
Tata Liquid Fund -Regular Plan - Growth Option
3Y Returns6.41%
Mirae Asset Liquid Fund - Growth
3Y Returns6.46%
Canara Robeco Blue Chip Equity Fund - Regular Plan - Growth Option
3Y Returns11.29%
Mirae Asset Large Cap Fund - Growth Plan
3Y Returns9.22%
HSBC Overnight Fund - Regular Growth
3Y Returns5.99%
DSP Overnight Fund - Regular Plan - Growth
3Y Returns6.02%
HDFC Flexi Cap Fund - Growth Plan
3Y Returns21.15%
PGIM India Flexi Cap Fund - Regular Plan - Growth Option
3Y Returns7.22%